Literature DB >> 16141953

[Positron emission tomographic studies of migraine].

G Géraud1, M Denuelle, N Fabre, P Payoux, F Chollet.   

Abstract

Due to technical constraints and randomness of migraine attacks, studies using PET are scarce. Nevertheless, these studies have given new insights into migraine pathogenesis. One of the main facts revealed by PET studies is that posterior cerebral hypoperfusion accompanying migraine auras could also be present in migraine attacks without aura. This hypoperfusion is probably due to an increase of intrinsic vasoconstrictive tone in the cerebral circulation. Using PET within 6 hours after the onset of a spontaneous migraine attack, significant activations of brainstem (midbrain and pons) and of hypothalamus, persisting after headache relief by sumatriptan have been shown. These structures could play the role of migraine attack generators, modulating intrinsic vascular tone and central pain transmission.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141953     DOI: 10.1016/s0035-3787(05)85111-2

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  5 in total

1.  The neurobiology of migraine.

Authors:  Andrew Charles; K C Brennan
Journal:  Handb Clin Neurol       Date:  2010

Review 2.  Pathophysiology of Migraine.

Authors:  H Evren Boran; Hayrunnisa Bolay
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

Review 3.  Migraine with and without aura share the same pathogenic mechanisms.

Authors:  R Allan Purdy
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

Review 4.  [Pathophysiology of migraine and clinical implications].

Authors:  M Schürks; H-C Diener
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

5.  Resting-state fMRI study of acute migraine treatment with kinetic oscillation stimulation in nasal cavity.

Authors:  Tie-Qiang Li; Yanlu Wang; Rolf Hallin; Jan-Erik Juto
Journal:  Neuroimage Clin       Date:  2016-08-15       Impact factor: 4.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.